SNCA and Parkinson disease: The degradation in neural function in Parkinson’s disease is evidenced by degeneration of substantia nigral neurons, accumulation of alpha-synuclein and Lewy bodies, cortical atrophy and alteration in neural oscillatory activity between basal ganglia, thalamus, cortex, and brainstem areas.